Reach Neuro

Giving control and independence back to people with stroke.

Pittsburgh, United States · Founded 2021 · $880K raised

Employees
1–10
Founded
2021
Business Model
B2B
Total Funding
$880K
Last Round
$200K SeedJun 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Reach Neuro is a neurotechnology startup developing spinal cord stimulation devices to restore shoulder, arm, and hand movement for people with chronic stroke and other neurological disorders. The company's Avantis platform — which received FDA Breakthrough Device designation in 2023 — uses implanted electrode arrays and a pulse generator to deliver personalized stimulation protocols that re-awaken the nervous system and directly restore a patient's ability to control their own movement. Co-founded by researchers from Brown University and the University of Pittsburgh, Reach Neuro is backed by SOSV and has demonstrated first-in-human results published in Nature Medicine.

Summary

Reach Neuro is a Healthcare company based in Pittsburgh, United States, founded in 2021. It has raised $880K in total across 2 rounds, most recently a $200K Seed round in Jun 2025. Investors include Angel Investor Forum, IndieBio and SOSV.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJun 2025
$200K

Sign up to see all 2 events

Funding: Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Neko Health

Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...

Stockholm, Sweden201–500Artificial Intelligence, Digital Health
Series CTotal funding$1.1BJul 2026
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Reach Neuro on Indexed.vc
<a href="https://indexed.vc/companies/reach-neuro"><img src="https://indexed.vc/api/badge/company/reach-neuro" alt="Reach Neuro on Indexed.vc" width="260" height="76" /></a>